| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 10775736 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 235 journal articles in the PubMed database | Email to a friend | | |
| Versi E, Appell R, Mobley D, et al.
Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. The Ditropan XL Study Group. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Obstet Gynecol 2000 May; 95(5):718-21.
Abstract | Full Citation | Find Related Articles | | Anderson RU, Mobley D, Blank B, et al.
Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Urol 1999 Jun; 161(6):1809-12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Corcos J, Casey R, Patrick A, et al.
A double-blind randomized dose-response study comparing daily doses of 5, 10 and 15 mg controlled-release oxybutynin: balancing efficacy with severity of dry mouth. [Journal Article, Multicenter Study, Randomized Controlled Trial]
BJU Int 2006 Mar; 97(3):520-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Davila GW, Daugherty CA, Sanders SW
A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Urol 2001 Jul; 166(1):140-5.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Gupta SK, Sathyan G, Lindemulder EA, et al.
Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Pharmacol Ther 1999 Jun; 65(6):672-84.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Gleason DM, Susset J, White C, et al.
Evaluation of a new once-daily formulation of oxbutynin for the treatment of urinary urge incontinence. Ditropan XL Study Group. [Clinical Trial, Journal Article, Multicenter Study]
Urology 1999 Sep; 54(3):420-3.
Abstract | Full Citation | Find Related Articles | | Diokno AC, Appell RA, Sand PK, et al.
Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Mayo Clin Proc 2003 Jun; 78(6):687-95.
Abstract | Full Citation | Find Related Articles | | Appell RA, Sand P, Dmochowski R, et al.
Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Mayo Clin Proc 2001 Apr; 76(4):358-63.
Abstract | Full Citation | Find Related Articles | | Barkin J, Corcos J, Radomski S, et al.
A randomized, double-blind, parallel-group comparison of controlled- and immediate-release oxybutynin chloride in urge urinary incontinence. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Ther 2004 Jul; 26(7):1026-36.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
